Pharmaceutical News

RSS

GlaxoSmithKline and Boehringer Ingelheim agree to assess the development of important HIV medicines for the developing world

GlaxoSmithKline plc and Boehringer Ingelheim announced today that both companies welcome the United States' continued involvement in the global response to HIV/AIDS.

17 May 2004

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

New international consensus guidelines for FUZEON (enfuvirtide) are published today in AIDS, the official journal of the International AIDS Society.

17 May 2004

HHS to ensure safe, effective drugs delivered to developing countries under the President's $15 billion plan for AIDS relief

HHS Secretary Tommy G. Thompson today announced an expedited review process to ensure that the United States is providing safe, effective drugs to developing countries under the President's $15 billion Emergency Plan for AIDS Relief.

16 May 2004

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

Bristol-Myers Squibb Company, Gilead Sciences, Inc. and Merck & Co., Inc. have announced that they are in discussions on the development of a once-daily, fixed-dose combination of three anti-HIV drugs and are also considering certain co-packaging options for the individual products.

16 May 2004

Drug discount card accepted across 41,000 US PCA pharmacies

Following Medicare's approval of its prescription drug discount card, the Pharmacy Care Alliance today announced that its growing network of pharmacies includes more than 31,000 chain and 10,000 independent representing more than 41,000 local pharmacies across the U.S.

16 May 2004

Influenza vaccine does provide protection against influenza in most asthma patients taking inhaled steroids

The influenza vaccine protected asthma patients who use inhaled steroids against type A flu, although its protection against type B flu was significantly reduced in those taking high doses of inhaled steroids, said a researcher from Baylor College of Medicine in a recent publication.

15 May 2004

FDA approval of topical anti-inflammatory cream

Atrix Laboratories, Inc. has announced the company received approval from the U.S. Food and Drug Administration (FDA) to market fluticasone propionate cream.

15 May 2004

The number of antibody-based medicines will climb dramatically

The number of antibodies in clinical development has leapt over the past six years and in 2004 hundreds are currently making their way through trials in what surely will be a spate of new product introductions beginning in 2004 and continuing over the next 10 years.

15 May 2004

Medicare drug discount cards continue to drop prices

After the first full week of making information on assured drug price discounts available to beneficiaries, the Centers for Medicare & Medicaid Services' review of the savings offered by drug card sponsors shows that more cards will be offering lower prices to beneficiaries, compared with prices posted last week.

15 May 2004

People with malaria who are too ill to take oral medication can benefit from rectal artesunate as initial treatment

People with moderate to severe malaria who are too ill to take oral medication can benefit from a single dose of rectal artesunate as initial treatment, conclude authors of a study in this week's issue of THE LANCET.

14 May 2004

FDA approves software that determines drug dosages of insulin

The FDA has approved a software suite developed by Dimensional Dosing Systems, Inc. for determining optimum drug dosages of insulin and many other drugs as well as combinations of drugs.

14 May 2004

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Britannia Pharmaceuticals Limited announced today that U.S.-based Bertek Pharmaceuticals Inc., the branded subsidiary of Mylan Laboratories Inc has received approval from the Food and Drug Administration for APOKYN (apomorphine hydrochloride injection).

13 May 2004

Genomed treatment helps bald eagles with West Nile virus encephalitis

GenoMed, Inc. a Next Generation Disease Management company that uses its expertise in genomics to improve clinical outcomes in as many species as possible, announced today that two non-profit groups which care for wild birds with West Nile virus encephalitis, including American bald eagles, will be using the Company's patent-pending treatment this season.

13 May 2004

New Canadian drug submission for cannabis-based medicine

GW Pharmaceuticals and Bayer HealthCare, Pharmaceuticals Division - Canada have announced that GW has submitted a New Drug Submission for Sativex®, a cannabis-based medicinal extract product, to Health Canada.

13 May 2004

Biochip technology to revolutionise the pharmaceutical industry

Advancements in biotechnology have culminated in its integration with semiconductor technologies such as micro-electromechanical systems, resulting in the evolution of biochips. Biochips provide pharma companies with sophisticated tools for speedy development of drugs and accurate diagnosis and understanding of biological mechanisms.

13 May 2004

Pharmaceutical News

GlaxoSmithKline and Boehringer Ingelheim agree to assess the development of important HIV medicines for the developing world

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

HHS to ensure safe, effective drugs delivered to developing countries under the President's $15 billion plan for AIDS relief

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

Drug discount card accepted across 41,000 US PCA pharmacies

Influenza vaccine does provide protection against influenza in most asthma patients taking inhaled steroids

FDA approval of topical anti-inflammatory cream

The number of antibody-based medicines will climb dramatically

Medicare drug discount cards continue to drop prices

People with malaria who are too ill to take oral medication can benefit from rectal artesunate as initial treatment

FDA approves software that determines drug dosages of insulin

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Genomed treatment helps bald eagles with West Nile virus encephalitis

New Canadian drug submission for cannabis-based medicine

Biochip technology to revolutionise the pharmaceutical industry

FDA knocks back King Pharmaceuticals self-injectible epilepsy product

Heart drug simvastatin will be available without a prescription

Phase 3 trial of Ceplene in acute myeloid leukemia meets primary trial endpoint

Cardiovascular marketing budgets hit $200 Million

Restrictions by health insurers and government to control expenses may hurt the malignant melanoma drug market

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News